首页> 外国专利> HUMAN MONOCLONAL ANTIBODY TO Fcalpha RECEPTOR (CD89)

HUMAN MONOCLONAL ANTIBODY TO Fcalpha RECEPTOR (CD89)

机译:人类单克隆抗体对Fcalpha受体(CD89)

摘要

PPROBLEM TO BE SOLVED: To provide a human monoclonal antibody specifically binding to Fc receptor (CD89) including a monoclonal antibody specifically reacting with the Fc receptor for IgA of human effector cells. PSOLUTION: An isolated monoclonal antibody comprising specific sequences of a heavy chain variable region and a light chain variable region and specifically binding to human Fc receptor (CD89), or an antigen-binding fragment thereof is provided. The antibody is a bifunctional antibody or a heteroantibody and is useful for targeting human effector cells (e.g. macrophage) against a target cell (e.g. a cancer cell, an infectious material and the like). PCOPYRIGHT: (C)2010,JPO&INPIT
机译:解决的问题:提供与Fc受体(CD89)特异性结合的人单克隆抗体,包括与人效应细胞的IgA的Fc受体特异性反应的单克隆抗体。解决方案:提供了一种分离的单克隆抗体,其包含重链可变区和轻链可变区的特定序列,并特异性结合人Fc受体(CD89),或其抗原结合片段。该抗体是双功能抗体或异源抗体,并且可用于将人效应细胞(例如巨噬细胞)靶向靶细胞(例如癌细胞,感染性物质等)。

版权:(C)2010,日本特许厅&INPIT

著录项

  • 公开/公告号JP2010004888A

    专利类型

  • 公开/公告日2010-01-14

    原文格式PDF

  • 申请/专利权人 CELLDEX THERAPEUTICS LTD;

    申请/专利号JP20090187733

  • 申请日2009-08-13

  • 分类号C12N15/09;C07K16/28;C07K16/46;A61K39/395;A61P1/16;A61P7/04;A61P13/12;C12P21/08;

  • 国家 JP

  • 入库时间 2022-08-21 19:05:16

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号